Form 4 for TYRA Tyra Biosciences, Inc.
Accepted 2024-06-10 00:00:00 ET · period of report 2024-06-07 · accession 0000950170-24-071500 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2024-06-10 | 2024-06-07+ | TYRA | Bensen Daniel | COO | S - Sale | $20.00 | -3,702 | 428.0K | -0.9% | -$74.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-07 | S | D | 200 | $20.00 | 431,483 | D | — | — | |
| 2 | Common | Common Stock | 2024-06-10 | S | D | 3,502 | $20.00 | 427,981 | D | — | — | (F2) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $20.00 to $20.03. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |